Intelligent active force control of human hand tremor using smart actuator

Patients suffering from Parkinson’s disease (PD) experience tremor which may generate a functional disability impacting their daily life activities. In order to provide a non-invasive solution, an active tremor control technique is proposed to suppress a human hand tremor. In this work, a hybrid controller which is a combination of the classic Proportional-Integral (PI) control and Active Force Control (AFC) strategy was employed. A test-rig is utilized as a practical test and verification platform of the controller design. A linear voice coil actuator (LVCA) was utilized as the main active suppressive element to control the tremor of hand model in collocation with the sensor. In order to validate the AFC scheme in real-time application, an accelerometer was used to obtain the measured values of the parameter necessary for the feedback control action. Meanwhile, a laser displacement sensor was used to quantify the displacement signal while hand shaking. To optimize the controller parameters, three different optimization techniques, namely the genetic algorithm (GA), particle swarm optimization (PSO) and differential evolution (DE) techniques were incorporated into the hybrid PI+AFC controller to obtain a better performance in controlling tremor of the system. For the simulation study, two different models were introduced to represent the human hand in the form of a mathematical model with four degree-of-freedom (4 DOF) biodynamic response (BR) and a parametric model as the plant model. The main objective of this investigation is to optimize the PI and AFC parameters using three different types of intelligent optimization techniques. Then, the parameters that have been identified were tested through an experimental work to evaluate the performance of controller. The findings of the study demonstrate that the hybrid controller gives excellent performance in reducing the tremor error in comparison to the classic pure PI controller. Based on the fitness evaluation, the AFC-based scheme enhances the PI controller performance roughly around 10% for all optimization techniques. Besides that, an intelligent mechanism known as iterative learning control (ILC) was incorporated into the AFC loop (called as AFCAIL) to find the estimated mass parameter. In addition, a sensitivity analysis was presented to investigate the performance and robustness of the voice coil actuator with the proposed controller in real-time environment. The results prove that the AFCAIL controller gives an excellent performance in reducing the hand tremor error in comparison with the classic P, PI and hybrid PI+AFC controllers. These outcomes provide an important contribution towards achieving novel methods in suppressing hand tremor by means of intelligent control

Medical Devices for Parkinson’s Disease

Background: Pharmacotherapy is the first-line treatment option for Parkinson’s disease, and levodopa is considered the most effective drug for managing motor symptoms. However, side effects such as motor fluctuation and dyskinesia have been associated with levodopa treatment. For these conditions, alternative therapies, including invasive and non-invasive medical devices, may be helpful. This review sheds light on current progress in the development of devices to alleviate motor symptoms in Parkinson’s disease. Methods: We first conducted a narrative literature review to obtain an overview of current invasive and non-invasive medical devices and thereafter performed a systematic review of recent randomized controlled trials (RCTs) of these devices. Results: Our review revealed different characteristics of each device and their effectiveness for motor symptoms. Although invasive medical devices are usually highly effective, surgical procedures can be burdensome for patients and have serious side effects. In contrast, non-pharmacological/non-surgical devices have fewer complications. RCTs of non-invasive devices, especially non-invasive brain stimulation and mechanical peripheral stimulation devices, have proven effectiveness on motor symptoms. Nearly no non-invasive devices have yet received Food and Drug Administration certification or a CE mark. Conclusion: Invasive and non-invasive medical devices have unique characteristics, and several RCTs have been conducted for each device. Invasive devices are more effective, while non-invasive devices are less effective and have lower hurdles and risks. It is important to understand the characteristics of each device and capitalize on these

4D printing of soft orthoses for tremor suppression

Tremor is an involuntary and oscillatory movement disorder that makes daily activities difficult for affected patients. Hand tremor-suppression orthoses are noninvasive, wearable devices designed to mitigate tremors. Various studies have shown that these devices are effective, economical, and safe; however, they have drawbacks such as large weight, awkward shape, and rigid parts. This study investigates different types of tremor-suppression orthoses and discusses their efficiency, mechanism, benefits, and disadvantages. First, various orthoses (with passive, semi-active, and active mechanisms) are described in detail. Next, we look at how additive manufacturing (AM) has progressed recently in making sensors and actuators for application in tremor orthoses. Then, the materials used in AM are further analyzed. It is found that traditional manufacturing problems can be solved with the help of AM techniques, like making orthoses that are affordable, lighter, and more customizable. Another concept being discussed is using smart materials and AM methods, such as four-dimensional (4D) printing, to make orthoses that are more comfortable and efficient

Intramuscular Stimulation of Muscle Afferents Attains Prolonged Tremor Reduction in Essential Tremor Patients

This study proposes and clinically tests intramuscular electrical stimulation below motor threshold to achieve prolonged reduction of wrist flexion/extension tremor in Essential Tremor (ET) patients. The developed system consisted of an intramuscular thin-film electrode structure that included both stimulation and electromyography (EMG) recording electrodes, and a control algorithm for the timing of intramuscular stimulation based on EMG (closed-loop stimulation). Data were recorded from nine ET patients with wrist flexion/extension tremor recruited from the Gregorio Mara\uf1\uf3n Hospital (Madrid, Spain). Patients participated in two experimental sessions comprising: 1) sensory stimulation of wrist flexors/extensors via thin-film multichannel intramuscular electrodes; and 2) surface stimulation of the nerves innervating the same target muscles. For each session, four of these patients underwent random 60-s trials of two stimulation strategies for each target muscle: 1) selective and adaptive timely stimulation (SATS) - based on EMG of the antagonist muscle; and 2) continuous stimulation (CON) of target muscles. Two patients underwent SATS stimulation trials alone while the other three underwent CON stimulation trials alone in each session. Kinematics of wrist, elbow, and shoulder, together with clinical scales, were used to assess tremor before, right after, and 24 h after each session. Intramuscular SATS achieved, on average, 32% acute (during stimulation) tremor reduction on each trial, while continuous stimulation augmented tremorgenic activity. Furthermore, tremor reduction was significantly higher using intramuscular than surface stimulation. Prolonged reduction of tremor amplitude (24 h after the experiment) was observed in four patients. These results showed acute and prolonged (24 h) tremor reduction using a minimally invasive neurostimulation technology based on SATS of primary sensory afferents of wrist muscles. This strategy might open the possibility of an alternative therapeutic approach for ET patients

Wearable inertial sensors for human movement analysis

Introduction: The present review aims to provide an overview of the most common uses of wearable inertial sensors in the field of clinical human movement analysis.Areas covered: Six main areas of application are analysed: gait analysis, stabilometry, instrumented clinical tests, upper body mobility assessment, daily-life activity monitoring and tremor assessment. Each area is analyzed both from a methodological and applicative point of view. The focus on the methodological approaches is meant to provide an idea of the computational complexity behind a variable/parameter/index of interest so that the reader is aware of the reliability of the approach. The focus on the application is meant to provide a practical guide for advising clinicians on how inertial sensors can help them in their clinical practice.Expert commentary: Less expensive and more easy to use than other systems used in human movement analysis, wearable sensors have evolved to the point that they can be considered ready for being part of routine clinical routine

Wired, wireless and wearable bioinstrumentation for high-precision recording of bioelectrical signals in bidirectional neural interfaces

It is widely accepted by the scientific community that bioelectrical signals, which can be used for the identification of neurophysiological biomarkers indicative of a diseased or pathological state, could direct patient treatment towards more effective therapeutic strategies. However, the design and realisation of an instrument that can precisely record weak bioelectrical signals in the presence of strong interference stemming from a noisy clinical environment is one of the most difficult challenges associated with the strategy of monitoring bioelectrical signals for diagnostic purposes. Moreover, since patients often have to cope with the problem of limited mobility being connected to bulky and mains-powered instruments, there is a growing demand for small-sized, high-performance and ambulatory biopotential acquisition systems in the Intensive Care Unit (ICU) and in High-dependency wards. Furthermore, electrical stimulation of specific target brain regions has been shown to alleviate symptoms of neurological disorders, such as Parkinson’s disease, essential tremor, dystonia, epilepsy etc. In recent years, the traditional practice of continuously stimulating the brain using static stimulation parameters has shifted to the use of disease biomarkers to determine the intensity and timing of stimulation. The main motivation behind closed-loop stimulation is minimization of treatment side effects by providing only the necessary stimulation required within a certain period of time, as determined from a guiding biomarker. Hence, it is clear that high-quality recording of local field potentials (LFPs) or electrocorticographic (ECoG) signals during deep brain stimulation (DBS) is necessary to investigate the instantaneous brain response to stimulation, minimize time delays for closed-loop neurostimulation and maximise the available neural data. To our knowledge, there are no commercial, small, battery-powered, wearable and wireless recording-only instruments that claim the capability of recording ECoG signals, which are of particular importance in closed-loop DBS and epilepsy DBS. In addition, existing recording systems lack the ability to provide artefact-free high-frequency (> 100 Hz) LFP recordings during DBS in real time primarily because of the contamination of the neural signals of interest by the stimulation artefacts. To address the problem of limited mobility often encountered by patients in the clinic and to provide a wide variety of high-precision sensor data to a closed-loop neurostimulation platform, a low-noise (8 nV/√Hz), eight-channel, battery-powered, wearable and wireless multi-instrument (55 × 80 mm2) was designed and developed. The performance of the realised instrument was assessed by conducting both ex vivo and in vivo experiments. The combination of desirable features and capabilities of this instrument, namely its small size (~one business card), its enhanced recording capabilities, its increased processing capabilities, its manufacturability (since it was designed using discrete off-the-shelf components), the wide bandwidth it offers (0.5 – 500 Hz) and the plurality of bioelectrical signals it can precisely record, render it a versatile tool to be utilized in a wide range of applications and environments. Moreover, in order to offer the capability of sensing and stimulating via the same electrode, novel real-time artefact suppression methods that could be used in bidirectional (recording and stimulation) system architectures are proposed and validated. More specifically, a novel, low-noise and versatile analog front-end (AFE), which uses a high-order (8th) analog Chebyshev notch filter to suppress the artefacts originating from the stimulation frequency, is presented. After defining the system requirements for concurrent LFP recording and DBS artefact suppression, the performance of the realised AFE is assessed by conducting both in vitro and in vivo experiments using unipolar and bipolar DBS (monophasic pulses, amplitude ranging from 3 to 6 V peak-to-peak, frequency 140 Hz and pulse width 100 µs). Under both in vitro and in vivo experimental conditions, the proposed AFE provided real-time, low-noise and artefact-free LFP recordings (in the frequency range 0.5 – 250 Hz) during stimulation. Finally, a family of tunable hardware filter designs and a novel method for real-time artefact suppression that enables wide-bandwidth biosignal recordings during stimulation are also presented. This work paves the way for the development of miniaturized research tools for closed-loop neuromodulation that use a wide variety of bioelectrical signals as control signals.Open Acces

Pathological Tremor as a Mechanical System: Modeling and Control of Artificial Muscle-Based Tremor Suppression

Central nervous system disorders produce the undesired, approximately rhythmic movement of body parts known as pathological tremor. This undesired motion inhibits the patient\u27s ability to perform tasks of daily living and participate in society. Typical treatments are medications and deep brain stimulation surgery, both of which include risks, side effects, and varying efficacy. Since the pathophysiology of tremor is not well understood, empirical investigation drives tremor treatment development. This dissertation explores tremor from a mechanical systems perspective to work towards theory-driven treatment design. The primary negative outcome of pathological tremor is the undesired movement of body parts: mechanically suppressing this motion provides effective tremor treatment by restoring limb function. Unlike typical treatments, the mechanisms for mechanical tremor suppression are well understood: applying joint torques that oppose tremor-producing muscular torques will reduce tremor irrespective of central nervous system pathophysiology. However, a tremor suppression system must also consider voluntary movements. For example, mechanically constraining the arm in a rigid cast eliminates tremor motion, but also eliminates the ability to produce voluntary motions. Indeed, passive mechanical systems typically reduce tremor and voluntary motions equally due to the close proximity of their frequency content. Thus, mechanical tremor suppression requires active actuation to reduce tremor with minimal influence on voluntary motion. However, typical engineering actuators are rigid and bulky, preventing clinical implementations. This dissertation explores dielectric elastomers as tremor suppression actuators to improve clinical implementation potential of mechanical tremor suppression. Dielectric elastomers are often called artificial muscles due to their similar mechanical properties as human muscle; these similarities may enable relatively soft, low-profile implementations. The primary drawback of dielectric elastomers is their relatively low actuation levels compared to typical actuators. This research develops a tremor-active approach to dielectric elastomer-based tremor suppression. In a tremor-active approach, the actuators only actuate to oppose tremor, while the human motor system must overcome the passive actuator dynamics. This approach leverages the low mechanical impedance of dielectric elastomers to overcome their low actuation levels. Simulations with recorded tremor datasets demonstrate excellent and robust tremor suppression performance. Benchtop experiments validate the control approach on a scaled system. Since dielectric elastomers are not yet commercially available, this research quantifies the necessary dielectric elastomer parameters to enable clinical implementations and evaluates the potential of manufacturing approaches in the literature to achieve these parameters. Overall, tremor-active control using dielectric elastomers represents a promising alternative to medications and surgery. Such a system may achieve comparable tremor reduction as medications and deep brain stimulation with minimal risks and greater efficacy, but at the cost of increased patient effort to produce voluntary motions. Parallel advances in scaled dielectric elastomer manufacturing processes and high-voltage power electronics will enable consumer implementations. In addition to tremor suppression, this dissertation investigates the mechanisms of central nervous system tremor generation from a control systems perspective. This research investigates a delay-based model for parkinsonian tremor. Besides tremor, Parkinson\u27s disease generally inhibits movement, with typical symptoms including rigidity, bradykinesia, and increased reaction times. This fact raises the question as to how the same disease produces excessive movement (tremor) despite characteristically inhibiting movement. One possible answer is that excessive central nervous system inhibition produces unaccounted feedback delays that cause instability. This dissertation develops an optimal control model of human motor control with an unaccounted delay between the state estimator and controller. This delay represents the increased inhibition projected from the basal ganglia to the thalamus, delaying signals traveling from the cerebellum (estimator) to the primary motor cortex (controller). Model simulations show increased delays decrease tremor frequency and increase tremor amplitude, consistent with the evolution of tremor as the disease progresses. Simulations that incorporate tremor resetting and random variation in control saturation produce simulated tremor with similar characteristics as recorded tremor. Delay-induced tremor explains the effectiveness of deep brain stimulation in both the thalamus and basal ganglia since both regions contribute to the presence of feedback delay. Clinical evaluation of mechanical tremor suppression may provide clinical evidence for delay-induced tremor: unlike state-independent tremor, suppression of delay-induced tremor increases tremor frequency. Altogether, establishing the mechanisms for tremor generation will facilitate pathways towards improved treatments and cure development

Active tremor control of human motion disorder

Thesis (S.M.)--Massachusetts Institute of Technology, Dept. of Mechanical Engineering, 2001.Includes bibliographical references (p. 141-142).All humans are subject to a physiological phenomenon known as tremor, which introduces unintended, relatively high-frequency movements into various parts of the body. These unintended movements serve to limit human motor performance with respect to normal human performance (for cases in which tremor is severe), and with respect to tasks that require "superhuman" performance (for cases in which not even normal tremor is tolerable). For example, the elderly often experience reduced motor control to the point where they can not eat. Similarly, surgeons performing eye surgery must have very little tremor to enable them to operate on the small anatomy of the eyes. In both cases, a motion disorder known as essential tremor can be the cause of the insufficient level of human motor performance. Current treatments for tremor disorders such as essential tremor include a small set of extremes (brain surgery versus doing nothing), with very little "middle ground." A device that could easily be placed onto the body and removed when not needed could fill this niche nicely. Due to the potential for high performance and portability, a new type of tremor stabilizer is proposed that uses a proof mass actuation scheme. This prototype device intended to attenuate human essential tremor along two translational axes was designed, constructed, and tested. Mechanical design, dynamics, and control systems modeling were performed, and the end device built to specifications. A shaker and experimental mount were constructed to artificially simulate tremor, and all data were gathered using this setup. The prototype demonstrated a 4:1 reduction in simulated tremor acceleration power from open- to closed-loop operation, as well as a 2:1 reduction in simulated tremor amplitude from open- to closed-loop operation. Medical personnel at Massachusetts General Hospital have suggested that this level of tremor attenuation would be helpful for their patients. Results were limited to vibrations along one of the two translational axes. Limitations of the prototype are discussed, as well as design strategies to improve performance in future work.by Gary Ellis Hall.S.M

Recent developments in the treatment of Parkinson's Disease.

Parkinson's disease (PD) is a common neurodegenerative disease typified by a movement disorder consisting of bradykinesia, rest tremor, rigidity, and postural instability. Treatment options for PD are limited, with most of the current approaches based on restoration of dopaminergic tone in the striatum. However, these do not alter disease course and do not treat the non-dopamine-dependent features of PD such as freezing of gait, cognitive impairment, and other non-motor features of the disorder, which often have the greatest impact on quality of life. As understanding of PD pathogenesis grows, novel therapeutic avenues are emerging. These include treatments that aim to control the symptoms of PD without the problematic side effects seen with currently available treatments and those that are aimed towards slowing pathology, reducing neuronal loss, and attenuating disease course. In this latter regard, there has been much interest in drug repurposing (the use of established drugs for a new indication), with many drugs being reported to affect PD-relevant intracellular processes. This approach offers an expedited route to the clinic, given that pharmacokinetic and safety data are potentially already available. In terms of better symptomatic therapies that are also regenerative, gene therapies and cell-based treatments are beginning to enter clinical trials, and developments in other neurosurgical strategies such as more nuanced deep brain stimulation approaches mean that the landscape of PD treatment is likely to evolve considerably over the coming years. In this review, we provide an overview of the novel therapeutic approaches that are close to, or are already in, clinical trials

Development of a Novel Handheld Device for Active Compensation of Physiological Tremor

In microsurgery, the human hand imposes certain limitations in accurately positioning the tip of a device such as scalpel. Any errors in the motion of the hand make microsurgical procedures difficult and involuntary motions such as hand tremors can make some procedures significantly difficult to perform. This is particularly true in the case of vitreoretinal microsurgery. The most familiar source of involuntary motion is physiological tremor. Real-time compensation of tremor is, therefore, necessary to assist surgeons to precisely position and manipulate the tool-tip to accurately perform a microsurgery. In this thesis, a novel handheld device (AID) is described for compensation of physiological tremor in the hand. MEMS-based accelerometers and gyroscopes have been used for sensing the motion of the hand in six degrees of freedom (DOF). An augmented state complementary Kalman filter is used to calculate 2 DOF orientation. An adaptive filtering algorithm, band-limited Multiple Fourier linear combiner (BMFLC), is used to calculate the tremor component in the hand in real-time. Ionic Polymer Metallic Composites (IPMCs) have been used as actuators for deflecting the tool-tip to compensate for the tremor